Review



murine c2c12 skeletal muscle myoblasts  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    ATCC murine c2c12 skeletal muscle myoblasts
    Concentration-dependent effects of sequentially prepared C. cassia stem-bark extracts on the <t>C2C12</t> MTT metabolic-viability signal after 72 h. The retained source figure displays 1.6, 3.125, 6.25, 12.5, 25, 50 and 100 μg/mL and the H 2 O 2 positive control; the originally reported 200-µg/mL and DMSO-control observations were not available for verification or replotting. Data represent three independent experiments performed in technical triplicate. Panels show (A) n-hexane, (B) ethyl acetate, (C) ethanol and (D) aqueous fractions. MTT reduction is interpreted as a metabolic-viability endpoint rather than direct cell number.
    Murine C2c12 Skeletal Muscle Myoblasts, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 8784 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/skeletal+muscle/C2C12/pmc13752183-93-0-5
    Average 99 stars, based on 8784 article reviews
    murine c2c12 skeletal muscle myoblasts - by Bioz Stars, 2026-11
    99/100 stars

    Images

    1) Product Images from "Differences in cytotoxicity and apparent extracellular glucose utilisation among sequentially prepared Cinnamomum cassia stem-bark extracts in basal and palmitate-associated C2C12 myotubes"

    Article Title: Differences in cytotoxicity and apparent extracellular glucose utilisation among sequentially prepared Cinnamomum cassia stem-bark extracts in basal and palmitate-associated C2C12 myotubes

    Journal: Frontiers in Pharmacology

    doi: 10.3389/fphar.2026.1971518

    Concentration-dependent effects of sequentially prepared C. cassia stem-bark extracts on the C2C12 MTT metabolic-viability signal after 72 h. The retained source figure displays 1.6, 3.125, 6.25, 12.5, 25, 50 and 100 μg/mL and the H 2 O 2 positive control; the originally reported 200-µg/mL and DMSO-control observations were not available for verification or replotting. Data represent three independent experiments performed in technical triplicate. Panels show (A) n-hexane, (B) ethyl acetate, (C) ethanol and (D) aqueous fractions. MTT reduction is interpreted as a metabolic-viability endpoint rather than direct cell number.
    Figure Legend Snippet: Concentration-dependent effects of sequentially prepared C. cassia stem-bark extracts on the C2C12 MTT metabolic-viability signal after 72 h. The retained source figure displays 1.6, 3.125, 6.25, 12.5, 25, 50 and 100 μg/mL and the H 2 O 2 positive control; the originally reported 200-µg/mL and DMSO-control observations were not available for verification or replotting. Data represent three independent experiments performed in technical triplicate. Panels show (A) n-hexane, (B) ethyl acetate, (C) ethanol and (D) aqueous fractions. MTT reduction is interpreted as a metabolic-viability endpoint rather than direct cell number.

    Techniques Used: Concentration Assay, Positive Control, Control

    Related Articles

    Isolation:

    Article Title: Assessment of mitochondrial viability under calcium Stress: Insights for mitochondrial transplantation
    Article Snippet: .. We used L6 ATCC CRL-1458 rat myoblast cells isolated from the skeletal muscle of the rat (ATCC, Manassas, VA, USA). ..

    Article Title: Proenkephalin expression and enkephalin release are widely observed in non-neuronal tissues.
    Article Snippet: Enkephalins are opioid peptides that are found at high levels in the brain and endocrine tissues.. Studies have shown that enkephalins play an important role in behavior, pain, cardiac function, cellular growth, immunity, and ischemic tolerance.. Our global hypothesis is that enkephalins are released from non-neuronal tissues in response to brief ischemia or exercise, and that this release contributes to cardioprotection.

    Article Title: Mitochondrial transplantation in cardiomyocytes: foundation, methods, and outcomes
    Article Snippet: .. Nonautologous (allogenic) mitochondria from skeletal muscle (rat L6; ATCC, Manassas, VA) cells were isolated using a commercially available isolation kit (ThermoFisher Scientific, Waltham, MA), labeled with MitoTracker Green FM (ThermoFisher Scientific, Waltham, MA), and transplanted to cardiomyocytes (rat H9c2; ATCC, Manassas, VA) via combination of centrifugation and coincubation. .. Success of mitochondrial transplantation was visualized using holotomography microscopy (Nanolive SA, Ecublens, Switzerland) 24 h posttransplantation.

    Article Title: Assessment of mitochondrial viability under calcium Stress: Insights for mitochondrial transplantation.
    Article Snippet: Mitochondrial transplantation has emerged as a promising cardioprotective strategy for ischemia-reperfusion injury, aiming to restore bioenergetic function by delivering healthy mitochondria to damaged tissue.. However, conflicting reports exist regarding whether mitochondria can survive exposure to the calcium-rich extracellular environment, such as the bloodstream, prior to cellular uptake.. Resolving this question is essential for advancing the therapeutic use of mitochondria in clinical settings.

    Article Title: Green solvent selection and extractin protocol for selective recovery of anti-diabetic components from T. crispa
    Article Snippet: .. The viabilities of myoblast cells isolated from the skeletal muscle of a rat (L6; ATCC; CRL1458) and hepatocellular carcinoma (HepG2; ATCC HB-8065) cells were evaluated using a method previously described (Suktham et al., 2018). ..

    Real-time Polymerase Chain Reaction:

    Article Title: Proenkephalin expression and enkephalin release are widely observed in non-neuronal tissues.
    Article Snippet: Enkephalins are opioid peptides that are found at high levels in the brain and endocrine tissues.. Studies have shown that enkephalins play an important role in behavior, pain, cardiac function, cellular growth, immunity, and ischemic tolerance.. Our global hypothesis is that enkephalins are released from non-neuronal tissues in response to brief ischemia or exercise, and that this release contributes to cardioprotection.

    Labeling:

    Article Title: Mitochondrial transplantation in cardiomyocytes: foundation, methods, and outcomes
    Article Snippet: .. Nonautologous (allogenic) mitochondria from skeletal muscle (rat L6; ATCC, Manassas, VA) cells were isolated using a commercially available isolation kit (ThermoFisher Scientific, Waltham, MA), labeled with MitoTracker Green FM (ThermoFisher Scientific, Waltham, MA), and transplanted to cardiomyocytes (rat H9c2; ATCC, Manassas, VA) via combination of centrifugation and coincubation. .. Success of mitochondrial transplantation was visualized using holotomography microscopy (Nanolive SA, Ecublens, Switzerland) 24 h posttransplantation.

    Centrifugation:

    Article Title: Mitochondrial transplantation in cardiomyocytes: foundation, methods, and outcomes
    Article Snippet: .. Nonautologous (allogenic) mitochondria from skeletal muscle (rat L6; ATCC, Manassas, VA) cells were isolated using a commercially available isolation kit (ThermoFisher Scientific, Waltham, MA), labeled with MitoTracker Green FM (ThermoFisher Scientific, Waltham, MA), and transplanted to cardiomyocytes (rat H9c2; ATCC, Manassas, VA) via combination of centrifugation and coincubation. .. Success of mitochondrial transplantation was visualized using holotomography microscopy (Nanolive SA, Ecublens, Switzerland) 24 h posttransplantation.

    Activity Assay:

    Article Title: Substituted bicyclic heteroaryl compounds as RXR agonists
    Article Snippet: .. 425.4 (M + H)+ Biological Activity The ability of the compounds of the invention to act as agonists of RXR and thus upregulate gene expression in a number of organs such as liver, skeletal muscle and adipose tissue was thus tested as follows: Liver (HepG2 Cells) Gene Expression Data: HepG2 cells (Source ATCC-cat no: HB-8065) were seeded in MEM media (6.9 mM glucose) containing 10% FBS (Fetal Bovine Serum) and cultured for 36 h. After 36 h of culture, cells were treated with 1 μM of candidate RXRa agonists in fresh MEM media (6.9 mM glucose and 10% FBS-Fetal Bovine Serum). .. After 24 h of treatment, supernatant was discarded and added Tri-reagent (Sigma, St. Louis, Mo., USA) to the cells.

    Gene Expression:

    Article Title: Substituted bicyclic heteroaryl compounds as RXR agonists
    Article Snippet: .. 425.4 (M + H)+ Biological Activity The ability of the compounds of the invention to act as agonists of RXR and thus upregulate gene expression in a number of organs such as liver, skeletal muscle and adipose tissue was thus tested as follows: Liver (HepG2 Cells) Gene Expression Data: HepG2 cells (Source ATCC-cat no: HB-8065) were seeded in MEM media (6.9 mM glucose) containing 10% FBS (Fetal Bovine Serum) and cultured for 36 h. After 36 h of culture, cells were treated with 1 μM of candidate RXRa agonists in fresh MEM media (6.9 mM glucose and 10% FBS-Fetal Bovine Serum). .. After 24 h of treatment, supernatant was discarded and added Tri-reagent (Sigma, St. Louis, Mo., USA) to the cells.

    Cell Culture:

    Article Title: Substituted bicyclic heteroaryl compounds as RXR agonists
    Article Snippet: .. 425.4 (M + H)+ Biological Activity The ability of the compounds of the invention to act as agonists of RXR and thus upregulate gene expression in a number of organs such as liver, skeletal muscle and adipose tissue was thus tested as follows: Liver (HepG2 Cells) Gene Expression Data: HepG2 cells (Source ATCC-cat no: HB-8065) were seeded in MEM media (6.9 mM glucose) containing 10% FBS (Fetal Bovine Serum) and cultured for 36 h. After 36 h of culture, cells were treated with 1 μM of candidate RXRa agonists in fresh MEM media (6.9 mM glucose and 10% FBS-Fetal Bovine Serum). .. After 24 h of treatment, supernatant was discarded and added Tri-reagent (Sigma, St. Louis, Mo., USA) to the cells.

    Derivative Assay:

    Article Title: Cultured muscle cells with high metabolic activity and method for production of the cultured muscle cells
    Article Snippet: .. Such cell strains include a mouse myoblast strain C2C12 (ATCC No. CRL1772), a myoblast cell strain L6 derived from the skeletal muscle of a rat (ATCC No. CRL1458), a rat cardiac myoblast cell strain H9C2 (ATCC No. CRL1446), etc. ..



    Similar Products

    94
    Cytoskeleton Inc biotin actin
    (A) Representative time-lapse images of TIRF reactions containing 1 µM actin (10% AlexaFluor-488, 3.6 nM <t>biotin-actin).</t> (B) TSOAX-generated filament traces (magenta) linked across successive frames for analysis in SMAUG. (C) Number of filaments per field of view (FOV) at 150 s measured manually and by SMAUG. For each condition, all filaments present in each FOV were counted across N = 3 independent reactions, with n = 9 FOVs total. Small dots represent individual FOVs and large dots indicate reaction means. Colors denote independent reactions. (D) SMAUG-generated kymograph of an individual actin filament from (A). (E) Representative filament length versus time plots generated from manual (black) and SMAUG (blue) measurements. (F) Mean filament elongation rates measured manually or by SMAUG. 17 filaments per FOV, were measured across N = 3 independent reactions (n = 153 filaments). Small dots represent individual filaments and large dots indicate reaction means. Colors denote independent reactions. (G) Representative time-lapse TIRF images of reactions containing increasing concentrations of actin (10% AlexaFluor-488, 3.6 nM biotin-actin). (H) TSOAX-generated filament traces (magenta), used for analysis in SMAUG. (I) Filament nucleation across actin concentration gradient. Each dot represents the filament count per FOV (n = 9, except 0.1 µM actin, where n = 12) from N = 3 independent experiments, except 0.1 µM, where N = 4. Inset, linear regression of mean nucleation values versus concentration (R 2 = 0.95). (J) Mean filament elongation rates at varied actin concentrations. 17 filaments per FOV, or all filaments if fewer were measured across N = 3 independent reactions (n = 153 filaments), except 0.1 µM actin (n = 70 filaments total) and 5 µM actin (n = 148 filaments total). 1 µM actin included N = 3 independent reactions. Small dots represent individual filaments and large dots indicate reaction means. Colors denote independent reactions. (K) Linear regression of mean filament elongation rates from (J) (R 2 = 0.99). Red lines indicate the 95% confidence interval of the regression line. Inset, expanded view of measurements at actin concentrations below 1 µM, showing that these values fall within the confidence interval of the regression line. Statistical comparisons between manual and SMAUG measurements were performed using Welch’s t-test (2C, p = 0.99; 2F, p = 0.55).
    Biotin Actin, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/skeletal+muscle/Actin+protein+(biotin)%3A+skeletal+muscle/bio_rxiv__64898__2026__11__05__764262-163-0-4
    Average 94 stars, based on 1 article reviews
    biotin actin - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    96
    PromoCell skeletal muscle growth medium
    (A) Representative time-lapse images of TIRF reactions containing 1 µM actin (10% AlexaFluor-488, 3.6 nM <t>biotin-actin).</t> (B) TSOAX-generated filament traces (magenta) linked across successive frames for analysis in SMAUG. (C) Number of filaments per field of view (FOV) at 150 s measured manually and by SMAUG. For each condition, all filaments present in each FOV were counted across N = 3 independent reactions, with n = 9 FOVs total. Small dots represent individual FOVs and large dots indicate reaction means. Colors denote independent reactions. (D) SMAUG-generated kymograph of an individual actin filament from (A). (E) Representative filament length versus time plots generated from manual (black) and SMAUG (blue) measurements. (F) Mean filament elongation rates measured manually or by SMAUG. 17 filaments per FOV, were measured across N = 3 independent reactions (n = 153 filaments). Small dots represent individual filaments and large dots indicate reaction means. Colors denote independent reactions. (G) Representative time-lapse TIRF images of reactions containing increasing concentrations of actin (10% AlexaFluor-488, 3.6 nM biotin-actin). (H) TSOAX-generated filament traces (magenta), used for analysis in SMAUG. (I) Filament nucleation across actin concentration gradient. Each dot represents the filament count per FOV (n = 9, except 0.1 µM actin, where n = 12) from N = 3 independent experiments, except 0.1 µM, where N = 4. Inset, linear regression of mean nucleation values versus concentration (R 2 = 0.95). (J) Mean filament elongation rates at varied actin concentrations. 17 filaments per FOV, or all filaments if fewer were measured across N = 3 independent reactions (n = 153 filaments), except 0.1 µM actin (n = 70 filaments total) and 5 µM actin (n = 148 filaments total). 1 µM actin included N = 3 independent reactions. Small dots represent individual filaments and large dots indicate reaction means. Colors denote independent reactions. (K) Linear regression of mean filament elongation rates from (J) (R 2 = 0.99). Red lines indicate the 95% confidence interval of the regression line. Inset, expanded view of measurements at actin concentrations below 1 µM, showing that these values fall within the confidence interval of the regression line. Statistical comparisons between manual and SMAUG measurements were performed using Welch’s t-test (2C, p = 0.99; 2F, p = 0.55).
    Skeletal Muscle Growth Medium, supplied by PromoCell, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/skeletal+muscle/Skeletal+Muscle+Cell+Growth+Medium/bio_rxiv__64898__2026__11__05__764057-400-8-12
    Average 96 stars, based on 1 article reviews
    skeletal muscle growth medium - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    94
    Cytoskeleton Inc actin binding kit
    (A) Representative time-lapse images of TIRF reactions containing 1 µM actin (10% AlexaFluor-488, 3.6 nM <t>biotin-actin).</t> (B) TSOAX-generated filament traces (magenta) linked across successive frames for analysis in SMAUG. (C) Number of filaments per field of view (FOV) at 150 s measured manually and by SMAUG. For each condition, all filaments present in each FOV were counted across N = 3 independent reactions, with n = 9 FOVs total. Small dots represent individual FOVs and large dots indicate reaction means. Colors denote independent reactions. (D) SMAUG-generated kymograph of an individual actin filament from (A). (E) Representative filament length versus time plots generated from manual (black) and SMAUG (blue) measurements. (F) Mean filament elongation rates measured manually or by SMAUG. 17 filaments per FOV, were measured across N = 3 independent reactions (n = 153 filaments). Small dots represent individual filaments and large dots indicate reaction means. Colors denote independent reactions. (G) Representative time-lapse TIRF images of reactions containing increasing concentrations of actin (10% AlexaFluor-488, 3.6 nM biotin-actin). (H) TSOAX-generated filament traces (magenta), used for analysis in SMAUG. (I) Filament nucleation across actin concentration gradient. Each dot represents the filament count per FOV (n = 9, except 0.1 µM actin, where n = 12) from N = 3 independent experiments, except 0.1 µM, where N = 4. Inset, linear regression of mean nucleation values versus concentration (R 2 = 0.95). (J) Mean filament elongation rates at varied actin concentrations. 17 filaments per FOV, or all filaments if fewer were measured across N = 3 independent reactions (n = 153 filaments), except 0.1 µM actin (n = 70 filaments total) and 5 µM actin (n = 148 filaments total). 1 µM actin included N = 3 independent reactions. Small dots represent individual filaments and large dots indicate reaction means. Colors denote independent reactions. (K) Linear regression of mean filament elongation rates from (J) (R 2 = 0.99). Red lines indicate the 95% confidence interval of the regression line. Inset, expanded view of measurements at actin concentrations below 1 µM, showing that these values fall within the confidence interval of the regression line. Statistical comparisons between manual and SMAUG measurements were performed using Welch’s t-test (2C, p = 0.99; 2F, p = 0.55).
    Actin Binding Kit, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/skeletal+muscle/Actin+Binding+Protein+Spin-Down+Assay+Biochem+Kit+rabbit+skeletal+muscle+actin/bio_rxiv__64898__2026__11__02__763837-76-15-18
    Average 94 stars, based on 1 article reviews
    actin binding kit - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    96
    Cytoskeleton Inc f actin
    (A) The core and headpiece (HP) domains of A. thaliana VILLIN4 isoform 2 (AtVLN4) are connected by a disordered linker.( , ) Fragments of AtVLN4 used in this work include are detailed in Fig. S2 : VL147N (basic portion of the linker, pI 11.7), VHP101C (acidic portion of the linker fused to the headpiece domain, pI 4.1), and Link-HP (full-length IDR linker fused to the headpiece domain). The location of the proposed <t>novel</t> <t>F-actin</t> bundling capability of the AtVLN4 linker is indicated with “**”. The grey rhombus separating VL147N and VHP101C is a predicted regulatory PEST motif (positions 866-876). (B) Amino acid sequence of the C-terminus of AtVLN4. This includes core domain 6 (residues 621-720, predicted by BlastP by sequence similarity to the analogous domain in G. gallus , PDB 2LLF, black underlined), and the C-terminal headpiece domain (residues 912-974, PDB 5VNT, blue underlined) connected via the IDR linker (residues 721-911, bold font). Similar to panel A , the basic, acidic, and PEST motif portions of the IDR linker are colored blue, red, and gray, respectively. In this work, the bulk of the PEST motif (SPAPESNS) between the basic and acidic segments has been mutated to AAAGGGAG to prevent premature sample degradation, which is the strategy which was successfully implemented for the sizable IDR in the related vertebrate protein dematin.
    F Actin, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/skeletal+muscle/Actin+protein+pure+rabbit+skeletal+muscle/bio_rxiv__64898__2026__11__02__763837-326-5-12
    Average 96 stars, based on 1 article reviews
    f actin - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    Cytoskeleton Inc rabbit muscle actin
    (A) The core and headpiece (HP) domains of A. thaliana VILLIN4 isoform 2 (AtVLN4) are connected by a disordered linker.( , ) Fragments of AtVLN4 used in this work include are detailed in Fig. S2 : VL147N (basic portion of the linker, pI 11.7), VHP101C (acidic portion of the linker fused to the headpiece domain, pI 4.1), and Link-HP (full-length IDR linker fused to the headpiece domain). The location of the proposed <t>novel</t> <t>F-actin</t> bundling capability of the AtVLN4 linker is indicated with “**”. The grey rhombus separating VL147N and VHP101C is a predicted regulatory PEST motif (positions 866-876). (B) Amino acid sequence of the C-terminus of AtVLN4. This includes core domain 6 (residues 621-720, predicted by BlastP by sequence similarity to the analogous domain in G. gallus , PDB 2LLF, black underlined), and the C-terminal headpiece domain (residues 912-974, PDB 5VNT, blue underlined) connected via the IDR linker (residues 721-911, bold font). Similar to panel A , the basic, acidic, and PEST motif portions of the IDR linker are colored blue, red, and gray, respectively. In this work, the bulk of the PEST motif (SPAPESNS) between the basic and acidic segments has been mutated to AAAGGGAG to prevent premature sample degradation, which is the strategy which was successfully implemented for the sizable IDR in the related vertebrate protein dematin.
    Rabbit Muscle Actin, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/skeletal+muscle/Actin+protein+pure+rabbit+skeletal+muscle/bio_rxiv__64898__2026__11__02__763837-326-0-12
    Average 96 stars, based on 1 article reviews
    rabbit muscle actin - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    Cytoskeleton Inc g actin
    (A) The core and headpiece (HP) domains of A. thaliana VILLIN4 isoform 2 (AtVLN4) are connected by a disordered linker.( , ) Fragments of AtVLN4 used in this work include are detailed in Fig. S2 : VL147N (basic portion of the linker, pI 11.7), VHP101C (acidic portion of the linker fused to the headpiece domain, pI 4.1), and Link-HP (full-length IDR linker fused to the headpiece domain). The location of the proposed <t>novel</t> <t>F-actin</t> bundling capability of the AtVLN4 linker is indicated with “**”. The grey rhombus separating VL147N and VHP101C is a predicted regulatory PEST motif (positions 866-876). (B) Amino acid sequence of the C-terminus of AtVLN4. This includes core domain 6 (residues 621-720, predicted by BlastP by sequence similarity to the analogous domain in G. gallus , PDB 2LLF, black underlined), and the C-terminal headpiece domain (residues 912-974, PDB 5VNT, blue underlined) connected via the IDR linker (residues 721-911, bold font). Similar to panel A , the basic, acidic, and PEST motif portions of the IDR linker are colored blue, red, and gray, respectively. In this work, the bulk of the PEST motif (SPAPESNS) between the basic and acidic segments has been mutated to AAAGGGAG to prevent premature sample degradation, which is the strategy which was successfully implemented for the sizable IDR in the related vertebrate protein dematin.
    G Actin, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/skeletal+muscle/Actin+protein+pure+rabbit+skeletal+muscle/pm42954380-441-2-4
    Average 96 stars, based on 1 article reviews
    g actin - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    99
    ATCC murine c2c12 skeletal muscle myoblasts
    Concentration-dependent effects of sequentially prepared C. cassia stem-bark extracts on the <t>C2C12</t> MTT metabolic-viability signal after 72 h. The retained source figure displays 1.6, 3.125, 6.25, 12.5, 25, 50 and 100 μg/mL and the H 2 O 2 positive control; the originally reported 200-µg/mL and DMSO-control observations were not available for verification or replotting. Data represent three independent experiments performed in technical triplicate. Panels show (A) n-hexane, (B) ethyl acetate, (C) ethanol and (D) aqueous fractions. MTT reduction is interpreted as a metabolic-viability endpoint rather than direct cell number.
    Murine C2c12 Skeletal Muscle Myoblasts, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/skeletal+muscle/C2C12/pmc13752183-93-0-5
    Average 99 stars, based on 1 article reviews
    murine c2c12 skeletal muscle myoblasts - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    99
    MyoLearn electromyography (emg) research
    Concentration-dependent effects of sequentially prepared C. cassia stem-bark extracts on the <t>C2C12</t> MTT metabolic-viability signal after 72 h. The retained source figure displays 1.6, 3.125, 6.25, 12.5, 25, 50 and 100 μg/mL and the H 2 O 2 positive control; the originally reported 200-µg/mL and DMSO-control observations were not available for verification or replotting. Data represent three independent experiments performed in technical triplicate. Panels show (A) n-hexane, (B) ethyl acetate, (C) ethanol and (D) aqueous fractions. MTT reduction is interpreted as a metabolic-viability endpoint rather than direct cell number.
    Electromyography (Emg) Research, supplied by MyoLearn, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/skeletal+muscle/Electromyography+(EMG)+Research/custom%40emg%4043005208
    Average 99 stars, based on 1 article reviews
    electromyography (emg) research - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    96
    Cytoskeleton Inc rabbit acta
    Concentration-dependent effects of sequentially prepared C. cassia stem-bark extracts on the <t>C2C12</t> MTT metabolic-viability signal after 72 h. The retained source figure displays 1.6, 3.125, 6.25, 12.5, 25, 50 and 100 μg/mL and the H 2 O 2 positive control; the originally reported 200-µg/mL and DMSO-control observations were not available for verification or replotting. Data represent three independent experiments performed in technical triplicate. Panels show (A) n-hexane, (B) ethyl acetate, (C) ethanol and (D) aqueous fractions. MTT reduction is interpreted as a metabolic-viability endpoint rather than direct cell number.
    Rabbit Acta, supplied by Cytoskeleton Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/skeletal+muscle/Actin+protein+pure+rabbit+skeletal+muscle/pm42912487-224-24-28
    Average 96 stars, based on 1 article reviews
    rabbit acta - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    94
    TaKaRa human adult skeletal muscle rna
    Concentration-dependent effects of sequentially prepared C. cassia stem-bark extracts on the <t>C2C12</t> MTT metabolic-viability signal after 72 h. The retained source figure displays 1.6, 3.125, 6.25, 12.5, 25, 50 and 100 μg/mL and the H 2 O 2 positive control; the originally reported 200-µg/mL and DMSO-control observations were not available for verification or replotting. Data represent three independent experiments performed in technical triplicate. Panels show (A) n-hexane, (B) ethyl acetate, (C) ethanol and (D) aqueous fractions. MTT reduction is interpreted as a metabolic-viability endpoint rather than direct cell number.
    Human Adult Skeletal Muscle Rna, supplied by TaKaRa, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/skeletal+muscle/Human+Skeletal+Muscle+Total+RNA/pm42894714-845-176-181
    Average 94 stars, based on 1 article reviews
    human adult skeletal muscle rna - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    Image Search Results


    (A) Representative time-lapse images of TIRF reactions containing 1 µM actin (10% AlexaFluor-488, 3.6 nM biotin-actin). (B) TSOAX-generated filament traces (magenta) linked across successive frames for analysis in SMAUG. (C) Number of filaments per field of view (FOV) at 150 s measured manually and by SMAUG. For each condition, all filaments present in each FOV were counted across N = 3 independent reactions, with n = 9 FOVs total. Small dots represent individual FOVs and large dots indicate reaction means. Colors denote independent reactions. (D) SMAUG-generated kymograph of an individual actin filament from (A). (E) Representative filament length versus time plots generated from manual (black) and SMAUG (blue) measurements. (F) Mean filament elongation rates measured manually or by SMAUG. 17 filaments per FOV, were measured across N = 3 independent reactions (n = 153 filaments). Small dots represent individual filaments and large dots indicate reaction means. Colors denote independent reactions. (G) Representative time-lapse TIRF images of reactions containing increasing concentrations of actin (10% AlexaFluor-488, 3.6 nM biotin-actin). (H) TSOAX-generated filament traces (magenta), used for analysis in SMAUG. (I) Filament nucleation across actin concentration gradient. Each dot represents the filament count per FOV (n = 9, except 0.1 µM actin, where n = 12) from N = 3 independent experiments, except 0.1 µM, where N = 4. Inset, linear regression of mean nucleation values versus concentration (R 2 = 0.95). (J) Mean filament elongation rates at varied actin concentrations. 17 filaments per FOV, or all filaments if fewer were measured across N = 3 independent reactions (n = 153 filaments), except 0.1 µM actin (n = 70 filaments total) and 5 µM actin (n = 148 filaments total). 1 µM actin included N = 3 independent reactions. Small dots represent individual filaments and large dots indicate reaction means. Colors denote independent reactions. (K) Linear regression of mean filament elongation rates from (J) (R 2 = 0.99). Red lines indicate the 95% confidence interval of the regression line. Inset, expanded view of measurements at actin concentrations below 1 µM, showing that these values fall within the confidence interval of the regression line. Statistical comparisons between manual and SMAUG measurements were performed using Welch’s t-test (2C, p = 0.99; 2F, p = 0.55).

    Journal: bioRxiv

    Article Title: Breaking the bottleneck: semi-automated quantification of actin filament dynamics

    doi: 10.64898/2026.11.05.764262

    Figure Lengend Snippet: (A) Representative time-lapse images of TIRF reactions containing 1 µM actin (10% AlexaFluor-488, 3.6 nM biotin-actin). (B) TSOAX-generated filament traces (magenta) linked across successive frames for analysis in SMAUG. (C) Number of filaments per field of view (FOV) at 150 s measured manually and by SMAUG. For each condition, all filaments present in each FOV were counted across N = 3 independent reactions, with n = 9 FOVs total. Small dots represent individual FOVs and large dots indicate reaction means. Colors denote independent reactions. (D) SMAUG-generated kymograph of an individual actin filament from (A). (E) Representative filament length versus time plots generated from manual (black) and SMAUG (blue) measurements. (F) Mean filament elongation rates measured manually or by SMAUG. 17 filaments per FOV, were measured across N = 3 independent reactions (n = 153 filaments). Small dots represent individual filaments and large dots indicate reaction means. Colors denote independent reactions. (G) Representative time-lapse TIRF images of reactions containing increasing concentrations of actin (10% AlexaFluor-488, 3.6 nM biotin-actin). (H) TSOAX-generated filament traces (magenta), used for analysis in SMAUG. (I) Filament nucleation across actin concentration gradient. Each dot represents the filament count per FOV (n = 9, except 0.1 µM actin, where n = 12) from N = 3 independent experiments, except 0.1 µM, where N = 4. Inset, linear regression of mean nucleation values versus concentration (R 2 = 0.95). (J) Mean filament elongation rates at varied actin concentrations. 17 filaments per FOV, or all filaments if fewer were measured across N = 3 independent reactions (n = 153 filaments), except 0.1 µM actin (n = 70 filaments total) and 5 µM actin (n = 148 filaments total). 1 µM actin included N = 3 independent reactions. Small dots represent individual filaments and large dots indicate reaction means. Colors denote independent reactions. (K) Linear regression of mean filament elongation rates from (J) (R 2 = 0.99). Red lines indicate the 95% confidence interval of the regression line. Inset, expanded view of measurements at actin concentrations below 1 µM, showing that these values fall within the confidence interval of the regression line. Statistical comparisons between manual and SMAUG measurements were performed using Welch’s t-test (2C, p = 0.99; 2F, p = 0.55).

    Article Snippet: Biotin-actin was purchased from Cytoskeleton, Inc. (Denver, CO) and resuspended in G-buffer according to the manufacturer’s instructions.

    Techniques: Generated, Analysis, Concentration Assay

    (A) Representative time-lapse TIRF images of 1 µM actin (10% AlexaFluor-488, 3.6 nM biotin-actin) polymerizing in the absence or presence of 1 µM profilin-1 (PFN1) or 5 nM mDia1(FH1-C), or the combination of both proteins for fast elongation. (B) TSOAX-generated filament traces (magenta) for the images in (A). (C) Number of filaments per field of view (FOV) at 150 s. All filaments were counted across N = 3 independent reactions (n = 9 FOVs). Small dots represent individual FOVs and large dots indicate reaction means. Colors denote independent reactions. (D) SMAUG-generated kymographs for the indicated conditions. (E) Representative filament length versus time plots. (F) Mean filament elongation rates. 17 filaments per FOV were measured across N = 3 independent reactions (n = 153; except actin & PFN1, n = 104; and actin, PFN1, & mDia1, n = 146). Small dots represent individual filaments and large dots indicate reaction means. Colors denote independent reactions. Statistical analysis was performed by one-way ANOVA with Tukey’s post-hoc test, with comparison to actin alone for reactions containing PFN1, mDia1, and both PFN1 and mDia1 (3C, p = 0.99, p = 0.05, and p = 0.70; 3F, p = 0.96, p = 0.99, and p < 0.01, respectively). Data are mean ± SD. All scale bars, 25 µm.

    Journal: bioRxiv

    Article Title: Breaking the bottleneck: semi-automated quantification of actin filament dynamics

    doi: 10.64898/2026.11.05.764262

    Figure Lengend Snippet: (A) Representative time-lapse TIRF images of 1 µM actin (10% AlexaFluor-488, 3.6 nM biotin-actin) polymerizing in the absence or presence of 1 µM profilin-1 (PFN1) or 5 nM mDia1(FH1-C), or the combination of both proteins for fast elongation. (B) TSOAX-generated filament traces (magenta) for the images in (A). (C) Number of filaments per field of view (FOV) at 150 s. All filaments were counted across N = 3 independent reactions (n = 9 FOVs). Small dots represent individual FOVs and large dots indicate reaction means. Colors denote independent reactions. (D) SMAUG-generated kymographs for the indicated conditions. (E) Representative filament length versus time plots. (F) Mean filament elongation rates. 17 filaments per FOV were measured across N = 3 independent reactions (n = 153; except actin & PFN1, n = 104; and actin, PFN1, & mDia1, n = 146). Small dots represent individual filaments and large dots indicate reaction means. Colors denote independent reactions. Statistical analysis was performed by one-way ANOVA with Tukey’s post-hoc test, with comparison to actin alone for reactions containing PFN1, mDia1, and both PFN1 and mDia1 (3C, p = 0.99, p = 0.05, and p = 0.70; 3F, p = 0.96, p = 0.99, and p < 0.01, respectively). Data are mean ± SD. All scale bars, 25 µm.

    Article Snippet: Biotin-actin was purchased from Cytoskeleton, Inc. (Denver, CO) and resuspended in G-buffer according to the manufacturer’s instructions.

    Techniques: Generated, Analysis, Comparison

    (A) Representative time-lapse TIRF images of 1 µM actin (10% AlexaFluor-488, 3.6 nM biotin-actin) polymerizing in the absence or presence of 10 nM capping protein (CP). (B) TSOAX-generated filament traces (magenta) for the images in (A). (C) Filament nucleation per field of view (FOV) at 150 s. All filaments were counted across N = 3 independent reactions (n = 9 FOVs). Small dots represent individual FOVs and large dots indicate reaction means. Colors denote independent reactions. (D) SMAUG-generated kymograph of an actin filament from a control reaction containing actin alone. (E) SMAUG-generated kymograph of an actin filament from a reaction containing CP. Active and paused filament elongation are labeled. (F) Representative filament length versus time plots. Red arrows indicate the onset of capping events, and the green arrow indicates a rare uncapping event where filament elongation resumed. (G) Mean filament elongation rates. 17 filaments per FOV, or all filaments if fewer, were measured across N = 3 independent reactions (n = 153 for actin alone; n = 150 for actin & CP). Small dots represent individual filaments and large dots indicate reaction means. Colors denote independent reactions. (H) Mean filament elongation rates during active and paused growth. Small dots represent individual filaments and large dots indicate reaction means. Colors denote independent reactions (N = 3; n = 115 filaments). (I) Percent of filaments with paused growth by 250 s. Each small dot represents one FOV (n = 9 FOVs from N = 3 independent reactions); large dots indicate reaction means and colors denote independent reactions. (J) Distribution of time to CP-induced pause events. Gaussian fit; R 2 = 0.76; mean ± SD. (K) Percentage of capped filaments over time. Data were averaged within each independent reaction before fitting to determine the capping rate constant (CRC = 0.0012 capping events s -1 ) and corresponding half-life (590.7 s). One representative fit is shown (R 2 = 0.99); data represent n = 9 FOVs from N = 3 independent reactions (mean ± SD). All scale bars, 25 µm. Statistical analysis, Welch’s t-test with actin alone control (4C, p = 0.14; 4G, p = 0.02; 4H, p = 0.02; 4I, p = 0.04).

    Journal: bioRxiv

    Article Title: Breaking the bottleneck: semi-automated quantification of actin filament dynamics

    doi: 10.64898/2026.11.05.764262

    Figure Lengend Snippet: (A) Representative time-lapse TIRF images of 1 µM actin (10% AlexaFluor-488, 3.6 nM biotin-actin) polymerizing in the absence or presence of 10 nM capping protein (CP). (B) TSOAX-generated filament traces (magenta) for the images in (A). (C) Filament nucleation per field of view (FOV) at 150 s. All filaments were counted across N = 3 independent reactions (n = 9 FOVs). Small dots represent individual FOVs and large dots indicate reaction means. Colors denote independent reactions. (D) SMAUG-generated kymograph of an actin filament from a control reaction containing actin alone. (E) SMAUG-generated kymograph of an actin filament from a reaction containing CP. Active and paused filament elongation are labeled. (F) Representative filament length versus time plots. Red arrows indicate the onset of capping events, and the green arrow indicates a rare uncapping event where filament elongation resumed. (G) Mean filament elongation rates. 17 filaments per FOV, or all filaments if fewer, were measured across N = 3 independent reactions (n = 153 for actin alone; n = 150 for actin & CP). Small dots represent individual filaments and large dots indicate reaction means. Colors denote independent reactions. (H) Mean filament elongation rates during active and paused growth. Small dots represent individual filaments and large dots indicate reaction means. Colors denote independent reactions (N = 3; n = 115 filaments). (I) Percent of filaments with paused growth by 250 s. Each small dot represents one FOV (n = 9 FOVs from N = 3 independent reactions); large dots indicate reaction means and colors denote independent reactions. (J) Distribution of time to CP-induced pause events. Gaussian fit; R 2 = 0.76; mean ± SD. (K) Percentage of capped filaments over time. Data were averaged within each independent reaction before fitting to determine the capping rate constant (CRC = 0.0012 capping events s -1 ) and corresponding half-life (590.7 s). One representative fit is shown (R 2 = 0.99); data represent n = 9 FOVs from N = 3 independent reactions (mean ± SD). All scale bars, 25 µm. Statistical analysis, Welch’s t-test with actin alone control (4C, p = 0.14; 4G, p = 0.02; 4H, p = 0.02; 4I, p = 0.04).

    Article Snippet: Biotin-actin was purchased from Cytoskeleton, Inc. (Denver, CO) and resuspended in G-buffer according to the manufacturer’s instructions.

    Techniques: Generated, Control, Labeling, Analysis

    (A) Representative time-lapse TIRF images of 1 µM actin (10% AlexaFluor-488, 3.6 nM biotin-actin) alone or supplemented with 100 nM Arp2/3 complex with and without 500 nM VCA (Arp2/3 complex activator). (B) TSOAX-generated filament traces for the images in (A). Yellow dots, filament-filament junction points identified by TSOAX. Yellow arrows, missed branch points. White arrows, misidentified branch points. (C) Filament nucleation per field of view (FOV) at 150 s. All filaments were counted across N = 3 independent reactions (n = 9 FOVs). Small dots represent individual FOVs and large dots indicate reaction means. Colors denote independent reactions. (D) Representative filament length versus time plots. (E) Mean filament elongation rates. 17 filaments per FOV were measured across N = 3 independent reactions (n = 153 filaments). Small dots represent individual filaments and large dots indicate reaction means. Colors denote independent reactions. (F) Number of filament-filament junctions per FOV at 150 s. All filament-filament crossing events were counted across N = independent reactions (n = 9 FOVs). Dots colored and represented as in (C). (G) Filament-filament junctions normalized to the number of filaments per FOV at 150 s. All filament-filament crossing events were counted across N = 3 independent reactions (n = 9 FOVs). Dots colored and represented as in (C). Statistical analysis was performed by one-way ANOVA with Tukey’s post-hoc test, with comparisons to actin alone with reactions containing Arp2/3 or Arp2/3 & VCA (5C, p = 0.30 and 0.97; 5E, p = 0.49 and p = 0.98; 5F, p = 0.63 and p = 0.88; 5G, p = 0.88 and p = 0.24, respectively). Data are mean ± SD. All scale bars, 25 µm.

    Journal: bioRxiv

    Article Title: Breaking the bottleneck: semi-automated quantification of actin filament dynamics

    doi: 10.64898/2026.11.05.764262

    Figure Lengend Snippet: (A) Representative time-lapse TIRF images of 1 µM actin (10% AlexaFluor-488, 3.6 nM biotin-actin) alone or supplemented with 100 nM Arp2/3 complex with and without 500 nM VCA (Arp2/3 complex activator). (B) TSOAX-generated filament traces for the images in (A). Yellow dots, filament-filament junction points identified by TSOAX. Yellow arrows, missed branch points. White arrows, misidentified branch points. (C) Filament nucleation per field of view (FOV) at 150 s. All filaments were counted across N = 3 independent reactions (n = 9 FOVs). Small dots represent individual FOVs and large dots indicate reaction means. Colors denote independent reactions. (D) Representative filament length versus time plots. (E) Mean filament elongation rates. 17 filaments per FOV were measured across N = 3 independent reactions (n = 153 filaments). Small dots represent individual filaments and large dots indicate reaction means. Colors denote independent reactions. (F) Number of filament-filament junctions per FOV at 150 s. All filament-filament crossing events were counted across N = independent reactions (n = 9 FOVs). Dots colored and represented as in (C). (G) Filament-filament junctions normalized to the number of filaments per FOV at 150 s. All filament-filament crossing events were counted across N = 3 independent reactions (n = 9 FOVs). Dots colored and represented as in (C). Statistical analysis was performed by one-way ANOVA with Tukey’s post-hoc test, with comparisons to actin alone with reactions containing Arp2/3 or Arp2/3 & VCA (5C, p = 0.30 and 0.97; 5E, p = 0.49 and p = 0.98; 5F, p = 0.63 and p = 0.88; 5G, p = 0.88 and p = 0.24, respectively). Data are mean ± SD. All scale bars, 25 µm.

    Article Snippet: Biotin-actin was purchased from Cytoskeleton, Inc. (Denver, CO) and resuspended in G-buffer according to the manufacturer’s instructions.

    Techniques: Generated, Analysis

    (A) Representative time-lapse TIRF images of 1 µM actin (10% AlexaFluor-488, 3.6 nM biotin-actin) polymerizing in the absence or presence of 1 µM fascin. (B) TSOAX-generated filament traces for the images in (A). (C) SMAUG-generated kymograph of an actin filament from a control reaction containing actin alone. (D) SMAUG-generated kymograph of an actin filament from a TIRF reaction containing fascin. Darker color on kymograph indicates increased fluorescence intensity. (E) Mean filament fluorescence intensity at 600 s. Intensity was measured along each segmented filament in the original image. 17 filaments per field of view (FOV) were measured across N = 3 independent reactions (n = 153 filaments). Small dots represent individual filaments and large dots indicate reaction means. Colors denote independent reactions. Statistical analysis was performed by Welch’s t-test compared to actin alone control (p = 0.05). Data are mean ± SD. (F) Mean filament fluorescence intensity over time. Lines represent the mean intensity of individual tracked filaments over time. Scale bars, 25 µm.

    Journal: bioRxiv

    Article Title: Breaking the bottleneck: semi-automated quantification of actin filament dynamics

    doi: 10.64898/2026.11.05.764262

    Figure Lengend Snippet: (A) Representative time-lapse TIRF images of 1 µM actin (10% AlexaFluor-488, 3.6 nM biotin-actin) polymerizing in the absence or presence of 1 µM fascin. (B) TSOAX-generated filament traces for the images in (A). (C) SMAUG-generated kymograph of an actin filament from a control reaction containing actin alone. (D) SMAUG-generated kymograph of an actin filament from a TIRF reaction containing fascin. Darker color on kymograph indicates increased fluorescence intensity. (E) Mean filament fluorescence intensity at 600 s. Intensity was measured along each segmented filament in the original image. 17 filaments per field of view (FOV) were measured across N = 3 independent reactions (n = 153 filaments). Small dots represent individual filaments and large dots indicate reaction means. Colors denote independent reactions. Statistical analysis was performed by Welch’s t-test compared to actin alone control (p = 0.05). Data are mean ± SD. (F) Mean filament fluorescence intensity over time. Lines represent the mean intensity of individual tracked filaments over time. Scale bars, 25 µm.

    Article Snippet: Biotin-actin was purchased from Cytoskeleton, Inc. (Denver, CO) and resuspended in G-buffer according to the manufacturer’s instructions.

    Techniques: Generated, Control, Fluorescence, Analysis

    (A) The core and headpiece (HP) domains of A. thaliana VILLIN4 isoform 2 (AtVLN4) are connected by a disordered linker.( , ) Fragments of AtVLN4 used in this work include are detailed in Fig. S2 : VL147N (basic portion of the linker, pI 11.7), VHP101C (acidic portion of the linker fused to the headpiece domain, pI 4.1), and Link-HP (full-length IDR linker fused to the headpiece domain). The location of the proposed novel F-actin bundling capability of the AtVLN4 linker is indicated with “**”. The grey rhombus separating VL147N and VHP101C is a predicted regulatory PEST motif (positions 866-876). (B) Amino acid sequence of the C-terminus of AtVLN4. This includes core domain 6 (residues 621-720, predicted by BlastP by sequence similarity to the analogous domain in G. gallus , PDB 2LLF, black underlined), and the C-terminal headpiece domain (residues 912-974, PDB 5VNT, blue underlined) connected via the IDR linker (residues 721-911, bold font). Similar to panel A , the basic, acidic, and PEST motif portions of the IDR linker are colored blue, red, and gray, respectively. In this work, the bulk of the PEST motif (SPAPESNS) between the basic and acidic segments has been mutated to AAAGGGAG to prevent premature sample degradation, which is the strategy which was successfully implemented for the sizable IDR in the related vertebrate protein dematin.

    Journal: bioRxiv

    Article Title: Actin filament bundling by the Arabidopsis VILLIN4 C-terminus involves the basic segment of the IDR linker and is sensitive to temperature and ionic strength

    doi: 10.64898/2026.11.02.763837

    Figure Lengend Snippet: (A) The core and headpiece (HP) domains of A. thaliana VILLIN4 isoform 2 (AtVLN4) are connected by a disordered linker.( , ) Fragments of AtVLN4 used in this work include are detailed in Fig. S2 : VL147N (basic portion of the linker, pI 11.7), VHP101C (acidic portion of the linker fused to the headpiece domain, pI 4.1), and Link-HP (full-length IDR linker fused to the headpiece domain). The location of the proposed novel F-actin bundling capability of the AtVLN4 linker is indicated with “**”. The grey rhombus separating VL147N and VHP101C is a predicted regulatory PEST motif (positions 866-876). (B) Amino acid sequence of the C-terminus of AtVLN4. This includes core domain 6 (residues 621-720, predicted by BlastP by sequence similarity to the analogous domain in G. gallus , PDB 2LLF, black underlined), and the C-terminal headpiece domain (residues 912-974, PDB 5VNT, blue underlined) connected via the IDR linker (residues 721-911, bold font). Similar to panel A , the basic, acidic, and PEST motif portions of the IDR linker are colored blue, red, and gray, respectively. In this work, the bulk of the PEST motif (SPAPESNS) between the basic and acidic segments has been mutated to AAAGGGAG to prevent premature sample degradation, which is the strategy which was successfully implemented for the sizable IDR in the related vertebrate protein dematin.

    Article Snippet: Rabbit muscle actin used for F-actin bundling testing was commercially acquired from Cytoskeleton.com (cat. # AKL99).

    Techniques: Sequencing

    (A) VL147N at 1.6 μM pulls down F-actin under low-speed centrifugation conditions. Lane 1: molecular weight standards (in kDa); lanes 3 and 5 in a dashed frame: centrifugation supernatant (S) and pellet (P) of VL147N in isolation (1.6 μM); lanes 7 and 9: centrifugation supernatant (S) and pellet (P) of VL147N (1.6 μM) mixed with F-actin. Solid rectangular frames in this and other panels indicate the supernatant (S) and pellet (P) fractions of the same pull-down experiment. (B) VL147N at 5.9 μM pulls down F-actin. Lane 1: molecular weight standards (in kDa); lanes 2 and 4: centrifugation supernatant (S) and pellet (P) of VL147N (5.9 μM) mixed with F-actin. (C) Control experiments at 21 °C. Lane 1: molecular weight standards (in kDa); lanes 2 and 3 (positive control): centrifugation supernatant (S) and pellet (P) of α-actinin (∼100 kDa; 1.0 μM) mixed with F-actin (10 μM); lanes 5 and 6 (negative control): centrifugation supernatant (S) and pellet (P) of BSA (∼66 kDa; 1.6 μM) mixed with F-actin (10 μM). (D) VHP101C at 5.9 μM does not pellet F-actin at 21 °C. Lane 1: molecular weight standards (in kDa). Lanes 3 and 5: centrifugation supernatant (S) and pellet (P) of VHP101C (5.9 μM) mixed with F-actin. Lanes 7 and 9 represent a duplicate trial of the same experiment.

    Journal: bioRxiv

    Article Title: Actin filament bundling by the Arabidopsis VILLIN4 C-terminus involves the basic segment of the IDR linker and is sensitive to temperature and ionic strength

    doi: 10.64898/2026.11.02.763837

    Figure Lengend Snippet: (A) VL147N at 1.6 μM pulls down F-actin under low-speed centrifugation conditions. Lane 1: molecular weight standards (in kDa); lanes 3 and 5 in a dashed frame: centrifugation supernatant (S) and pellet (P) of VL147N in isolation (1.6 μM); lanes 7 and 9: centrifugation supernatant (S) and pellet (P) of VL147N (1.6 μM) mixed with F-actin. Solid rectangular frames in this and other panels indicate the supernatant (S) and pellet (P) fractions of the same pull-down experiment. (B) VL147N at 5.9 μM pulls down F-actin. Lane 1: molecular weight standards (in kDa); lanes 2 and 4: centrifugation supernatant (S) and pellet (P) of VL147N (5.9 μM) mixed with F-actin. (C) Control experiments at 21 °C. Lane 1: molecular weight standards (in kDa); lanes 2 and 3 (positive control): centrifugation supernatant (S) and pellet (P) of α-actinin (∼100 kDa; 1.0 μM) mixed with F-actin (10 μM); lanes 5 and 6 (negative control): centrifugation supernatant (S) and pellet (P) of BSA (∼66 kDa; 1.6 μM) mixed with F-actin (10 μM). (D) VHP101C at 5.9 μM does not pellet F-actin at 21 °C. Lane 1: molecular weight standards (in kDa). Lanes 3 and 5: centrifugation supernatant (S) and pellet (P) of VHP101C (5.9 μM) mixed with F-actin. Lanes 7 and 9 represent a duplicate trial of the same experiment.

    Article Snippet: Rabbit muscle actin used for F-actin bundling testing was commercially acquired from Cytoskeleton.com (cat. # AKL99).

    Techniques: Centrifugation, Molecular Weight, Isolation, Pull Down Assay, Control, Positive Control, Negative Control

    Black lines and white arrows mark the positions for the actin and VL147N gel bands. (A) Lane 1: molecular weight standards (in kDa); lanes 3 and 5: VL147N (1.6 μM) mixed with F-actin centrifugation, supernatant (S) and pellet (P) fractions at 21 °C. (B) Lane 1: molecular weight standards (in kDa); lanes 3 and 5: centrifugation supernatant (S) and pellet (P) of VL147N (1.6 μM) mixed with F-actin at 4 °C. (C) Lane 1: molecular weight standards (in kDa); lanes 2 and 4: centrifugation supernatant (S) and pellet (P) of VL147N (5.9 μM) mixed with F-actin at 21 °C. (D) Lane 1: molecular weight standards (in kDa); lanes 3 and 5: centrifugation supernatant (S) and pellet (P) of VL147N (5.9 μM) mixed with F-actin at 4 °C. (E-H) Link-HP bundles F-actin weaker than VL147N but the bundling is restored by 100 mM KCl. All the tests here were done at 21 °C and in the presence of 50 mM NaCl. Concentration values of 5.9 μM were used for VL147N and Link-HP. (E) Lane 1: molecular weight standards (in kDa); lanes 2 and 4: centrifugation supernatant (S) and pellet (P) of VL147N (5.9 μM) mixed with F-actin in the absence of KCl at 21 °C. (F) Lane 1: molecular weight standards (in kDa); lanes 3 and 5: centrifugation supernatant (S) and pellet (P) of Link-HP (5.9 μM) mixed with F-actin in the absence of KCl at 21 °C. (G) Lane 1: molecular weight standards (in kDa); lanes 3 and 5: centrifugation supernatant (S) and pellet (P) of VL147N (5.9 μM) mixed with F-actin in the presence of 100 mM KCl at 21 °C. (H) Lane 1: molecular weight standards (in kDa); lanes 3 and 5: centrifugation supernatant (S) and pellet (P) of Link-HP (5.9 μM) mixed with F-actin in the presence of 100 mM KCl at 21 °C.

    Journal: bioRxiv

    Article Title: Actin filament bundling by the Arabidopsis VILLIN4 C-terminus involves the basic segment of the IDR linker and is sensitive to temperature and ionic strength

    doi: 10.64898/2026.11.02.763837

    Figure Lengend Snippet: Black lines and white arrows mark the positions for the actin and VL147N gel bands. (A) Lane 1: molecular weight standards (in kDa); lanes 3 and 5: VL147N (1.6 μM) mixed with F-actin centrifugation, supernatant (S) and pellet (P) fractions at 21 °C. (B) Lane 1: molecular weight standards (in kDa); lanes 3 and 5: centrifugation supernatant (S) and pellet (P) of VL147N (1.6 μM) mixed with F-actin at 4 °C. (C) Lane 1: molecular weight standards (in kDa); lanes 2 and 4: centrifugation supernatant (S) and pellet (P) of VL147N (5.9 μM) mixed with F-actin at 21 °C. (D) Lane 1: molecular weight standards (in kDa); lanes 3 and 5: centrifugation supernatant (S) and pellet (P) of VL147N (5.9 μM) mixed with F-actin at 4 °C. (E-H) Link-HP bundles F-actin weaker than VL147N but the bundling is restored by 100 mM KCl. All the tests here were done at 21 °C and in the presence of 50 mM NaCl. Concentration values of 5.9 μM were used for VL147N and Link-HP. (E) Lane 1: molecular weight standards (in kDa); lanes 2 and 4: centrifugation supernatant (S) and pellet (P) of VL147N (5.9 μM) mixed with F-actin in the absence of KCl at 21 °C. (F) Lane 1: molecular weight standards (in kDa); lanes 3 and 5: centrifugation supernatant (S) and pellet (P) of Link-HP (5.9 μM) mixed with F-actin in the absence of KCl at 21 °C. (G) Lane 1: molecular weight standards (in kDa); lanes 3 and 5: centrifugation supernatant (S) and pellet (P) of VL147N (5.9 μM) mixed with F-actin in the presence of 100 mM KCl at 21 °C. (H) Lane 1: molecular weight standards (in kDa); lanes 3 and 5: centrifugation supernatant (S) and pellet (P) of Link-HP (5.9 μM) mixed with F-actin in the presence of 100 mM KCl at 21 °C.

    Article Snippet: Rabbit muscle actin used for F-actin bundling testing was commercially acquired from Cytoskeleton.com (cat. # AKL99).

    Techniques: Molecular Weight, Centrifugation, Concentration Assay

    Also see Table S1 . Bars indicate the mean of three replicates ± SE. p -values are indicated over horizontal bars for selected comparisons; actin-only comparisons were similar to Actin +BSA comparisons and were omitted for clarity. Statistics were calculated using Welch’s two-sample t -test with a Holm-Bonferroni correction to ensure an experiment wide α = 0.05. Asterisks indicate significance after correction for multiple comparisons. (A) F-actin bundling capacity of VL147N was significantly reduced at low temperature (4 °C) compared to 21 °C. Experiments were performed in the absence of KCl, VL147N concentration was 1.6 µM; BSA concentration was 4.4 µM for all replicates (n = 3). (B) Link-HP F-actin bundling increased in the presence of 100 µM KCl. Experiments were performed at 21 °C, VL147N concentration was 5.9 µM; Link-HP concentration was 5.9 µM, BSA concentration was 4.4 µM for all replicates (n = 3). VHP101C displayed limited capacity for actin bundling in our tests (not shown).

    Journal: bioRxiv

    Article Title: Actin filament bundling by the Arabidopsis VILLIN4 C-terminus involves the basic segment of the IDR linker and is sensitive to temperature and ionic strength

    doi: 10.64898/2026.11.02.763837

    Figure Lengend Snippet: Also see Table S1 . Bars indicate the mean of three replicates ± SE. p -values are indicated over horizontal bars for selected comparisons; actin-only comparisons were similar to Actin +BSA comparisons and were omitted for clarity. Statistics were calculated using Welch’s two-sample t -test with a Holm-Bonferroni correction to ensure an experiment wide α = 0.05. Asterisks indicate significance after correction for multiple comparisons. (A) F-actin bundling capacity of VL147N was significantly reduced at low temperature (4 °C) compared to 21 °C. Experiments were performed in the absence of KCl, VL147N concentration was 1.6 µM; BSA concentration was 4.4 µM for all replicates (n = 3). (B) Link-HP F-actin bundling increased in the presence of 100 µM KCl. Experiments were performed at 21 °C, VL147N concentration was 5.9 µM; Link-HP concentration was 5.9 µM, BSA concentration was 4.4 µM for all replicates (n = 3). VHP101C displayed limited capacity for actin bundling in our tests (not shown).

    Article Snippet: Rabbit muscle actin used for F-actin bundling testing was commercially acquired from Cytoskeleton.com (cat. # AKL99).

    Techniques: Concentration Assay

    Solid arrows point to at least six cases of VL147N signals (3 °C, black) which have no match in the Link-HP data (4 °C, red). These signals are also labeled with letters, a-f. The buffers in both cases lacked KCl to mimic the environment of the F-actin bundling tests described in and .

    Journal: bioRxiv

    Article Title: Actin filament bundling by the Arabidopsis VILLIN4 C-terminus involves the basic segment of the IDR linker and is sensitive to temperature and ionic strength

    doi: 10.64898/2026.11.02.763837

    Figure Lengend Snippet: Solid arrows point to at least six cases of VL147N signals (3 °C, black) which have no match in the Link-HP data (4 °C, red). These signals are also labeled with letters, a-f. The buffers in both cases lacked KCl to mimic the environment of the F-actin bundling tests described in and .

    Article Snippet: Rabbit muscle actin used for F-actin bundling testing was commercially acquired from Cytoskeleton.com (cat. # AKL99).

    Techniques: Labeling

    Concentration-dependent effects of sequentially prepared C. cassia stem-bark extracts on the C2C12 MTT metabolic-viability signal after 72 h. The retained source figure displays 1.6, 3.125, 6.25, 12.5, 25, 50 and 100 μg/mL and the H 2 O 2 positive control; the originally reported 200-µg/mL and DMSO-control observations were not available for verification or replotting. Data represent three independent experiments performed in technical triplicate. Panels show (A) n-hexane, (B) ethyl acetate, (C) ethanol and (D) aqueous fractions. MTT reduction is interpreted as a metabolic-viability endpoint rather than direct cell number.

    Journal: Frontiers in Pharmacology

    Article Title: Differences in cytotoxicity and apparent extracellular glucose utilisation among sequentially prepared Cinnamomum cassia stem-bark extracts in basal and palmitate-associated C2C12 myotubes

    doi: 10.3389/fphar.2026.1971518

    Figure Lengend Snippet: Concentration-dependent effects of sequentially prepared C. cassia stem-bark extracts on the C2C12 MTT metabolic-viability signal after 72 h. The retained source figure displays 1.6, 3.125, 6.25, 12.5, 25, 50 and 100 μg/mL and the H 2 O 2 positive control; the originally reported 200-µg/mL and DMSO-control observations were not available for verification or replotting. Data represent three independent experiments performed in technical triplicate. Panels show (A) n-hexane, (B) ethyl acetate, (C) ethanol and (D) aqueous fractions. MTT reduction is interpreted as a metabolic-viability endpoint rather than direct cell number.

    Article Snippet: Murine C2C12 skeletal muscle myoblasts (ATCC CRL-1772) were cultured in Dulbecco’s Modified Eagle Medium (DMEM; Gibco, Thermo Fisher Scientific, United States) supplemented with 10% heat-inactivated fetal bovine serum and 1% penicillin–streptomycin, providing final concentrations of 100 U/mL penicillin and 100 μg/mL streptomycin.

    Techniques: Concentration Assay, Positive Control, Control